Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
Sponsor: Beijing Ditan Hospital
Summary
Establish a study cohort of adult chronic hepatitis B antiviral treatment based on the principle of responseguidedtreatment (RGT) corresponding to the child cohort, analyze the clinical cure factors of IC and IT stage adults chronic hepatitis B, and optimize the antiviral treatment plan. To determine the safety and efficacy of PD-1 antibody combined with Peg-FNa-2b in the treatment of adult NAs patients with CHB advantage.
Official title: Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for Chronic Hepatitis B in Adults
Key Details
Gender
FEMALE
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2023-12-01
Completion Date
2026-11-01
Last Updated
2025-01-15
Healthy Volunteers
No
Conditions
Interventions
Peg interferon alfa-2b
NA combined with Peg interferon alfa-2b
Locations (1)
Beijing Ditan hospital
Beijing, China